IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12076089 B1

PDFFull Text
Date of Patent:
Sep. 03, 2024

Filed:

Jul. 25, 2022

Denervation therapy

Applicant:

Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;

Inventors:

Paul J. Coates, Corte Madera, CA (US);

Douglas A. Hettrick, Andover, MN (US);

Assignee:

Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;

Attorney:

Shumaker & Sieffert, P.A

Primary Examiner:

Catherine M Voorhees

Int. Cl.
CPC ...
A61B 34/10 (2016.01); A61B 5/00 (2006.01); A61B 5/0536 (2021.01); A61B 5/055 (2006.01); A61B 5/20 (2006.01); A61B 6/03 (2006.01); A61B 6/46 (2024.01); A61B 6/50 (2024.01); A61B 8/08 (2006.01); A61B 18/00 (2006.01); A61B 18/06 (2006.01); A61B 18/14 (2006.01); A61B 18/24 (2006.01); A61B 34/00 (2016.01); A61B 90/00 (2016.01); G16H 50/50 (2018.01); A61B 6/00 (2006.01); A61B 6/12 (2006.01); A61B 8/00 (2006.01); A61B 17/32 (2006.01); A61B 18/02 (2006.01); A61B 18/18 (2006.01); A61B 34/20 (2016.01);
U.S. Cl.
CPC ...
A61B 34/10 (2016.02); A61B 5/0066 (2013.01); A61B 5/0536 (2013.01); A61B 5/055 (2013.01); A61B 5/201 (2013.01); A61B 5/40 (2013.01); A61B 5/4041 (2013.01); A61B 5/4047 (2013.01); A61B 5/4052 (2013.01); A61B 5/407 (2013.01); A61B 6/032 (2013.01); A61B 6/037 (2013.01); A61B 6/461 (2013.01); A61B 6/506 (2013.01); A61B 8/0891 (2013.01); A61B 18/06 (2013.01); A61B 18/1492 (2013.01); A61B 18/24 (2013.01); A61B 34/25 (2016.02); A61B 90/37 (2016.02); G16H 50/50 (2018.01); A61B 6/00 (2013.01); A61B 6/12 (2013.01); A61B 6/465 (2013.01); A61B 8/0841 (2013.01); A61B 8/085 (2013.01); A61B 8/461 (2013.01); A61B 2017/320069 (2017.08); A61B 2018/00351 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/1435 (2013.01); A61B 2018/1861 (2013.01); A61B 2034/104 (2016.02); A61B 2034/107 (2016.02); A61B 34/20 (2016.02); A61B 2090/3735 (2016.02); A61B 2090/374 (2016.02); A61B 2090/376 (2016.02); A61B 2090/3762 (2016.02); A61B 2090/378 (2016.02); A61B 2090/3954 (2016.02); A61B 2090/3958 (2016.02); A61B 2090/3966 (2016.02);
Abstract

Example systems and techniques for denervation, for example, renal denervation. In some examples, a processor determines one or more tissue characteristics of tissue proximate a target nerve and a blood vessel. The processor may generate, based on the one or more tissue characteristics, an estimated volume of influence of denervation therapy delivered by a therapy delivery device disposed within the blood vessel. The processor may generate a graphical user interface including a graphical representation of the tissue proximate the target nerve and the blood vessel and a graphical representation of the estimated volume of influence.

Find Patent Forward Citations

Loading…